Columbia University Medical Center.
Behav Ther. 2013 Mar;44(1):88-99. doi: 10.1016/j.beth.2012.07.001. Epub 2012 Jul 24.
The current study examines participants' attributions of change in a double-blind, randomized controlled trial of problem drinkers wanting to moderate their alcohol consumption. Participants were assigned to 12 weeks of naltrexone or placebo, which was paired with either combined motivational interviewing and cognitive behavioral therapy (MBSCT) along with an enhanced medication management intervention or enhanced medication management only. Upon treatment completion, a questionnaire assessed participants' attributions of change along with their self-efficacy in their ability to maintain treatment gains. Participants differed in strength of attributions of change and self-efficacy according to both their therapy condition and their hypothesized medication condition. Specifically, those in the MBSCT condition who hypothesized that they received placebo displayed greater confidence in continuing changes without medication compared with the other groups. How treatment condition and attributions of change relate to self-efficacy for long-term maintenance of treatment gains are discussed.
本研究考察了在一项针对希望适度饮酒的问题饮酒者的双盲、随机对照试验中，参与者对变化的归因。参与者被分配到为期 12 周的纳曲酮或安慰剂组，同时接受联合动机访谈和认知行为疗法（MBSCT）以及增强药物管理干预或仅增强药物管理。治疗完成后，一份问卷评估了参与者对变化的归因以及他们保持治疗效果的能力的自我效能感。参与者根据他们的治疗条件和假设的药物条件，在变化归因和自我效能感方面存在差异。具体来说，那些在 MBSCT 条件下假设自己接受安慰剂的人，与其他组相比，对在没有药物的情况下继续改变表现出更大的信心。讨论了治疗条件和归因变化如何与长期维持治疗效果的自我效能感相关。
